Researchers who administered an antibody to neutralise an OCD-associated protein in mice found it reduced their anxious behaviours.
List view / Grid view
obsessive-compulsive disorder (OCD)
Filter the results
The first drug designed using artificial intelligence (AI) has moved into its Phase I trial. Professor Andrew Hopkins of Exscientia explains how an algorithm was used to achieve this milestone.